Streetbeat News

Analyst Ratings

WDFC

DA Davidson has maintained its Buy rating for WD-40 (NASDAQ:WDFC) and increased its price target from $232.00 to $256.00. This new target price represents a 26.22% increase from the current share price. WD-40's shares have risen by 1.15% over the last 24 hours.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 5:00 pm

BLRX

BioLineRx Ltd (NASDAQ:BLRX) announced encouraging data from the pilot phase of the CheMo4METPANC Phase 2 trial for first-line pancreatic cancer. The trial showed a disease control rate of 82%, compared to historic rates of 48%. Based on these results, the trial was amended to become a randomized study with increased enrollment. Earlier this month, the FDA approved BioLineRx's Aphexda for use in patients with multiple myeloma. However, BLRX shares are down 6.28% at $1.94.

Portfolio Pulse from Vandana Singh

September 28, 2023 | 4:55 pm

MU

Micron Technology's Q4 results were largely in line with expectations, but shares fell in early trading. Analysts from BMO Capital Markets, Piper Sandler, Mizuho Securities, Stifel, BofA Securities, Needham, and Morgan Stanley provided their takeaways. Most analysts maintained their ratings, with price targets ranging from $58 to $82. Key points included excess inventory clearing in most end markets, expectations of improving inventory levels, and anticipation of DRAM and NAND pricing improvement into 2024.

Portfolio Pulse from Priya Nigam

September 28, 2023 | 4:45 pm

BNOX

Maxim Group analyst Jason McCarthy maintains a 'Buy' rating on Bionomics (NASDAQ:BNOX) and raises the price target from $7 to $10.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 4:43 pm

TSLA

Tesla shares are trading higher amid the ongoing UAW strikes at the company's Big 3 rivals. Morgan Stanley has maintained an Overweight rating and a $400 price target on the stock.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 4:43 pm

NVDA

TSLA

The popularity of AI stocks, particularly Nvidia Corp. (NASDAQ:NVDA), has surged, while interest in electric vehicle stocks like Tesla Inc. (NASDAQ:TSLA) has waned. Over the past year, Nvidia's price has increased by 233.6%, while Tesla's has fallen by 16.5%. Both companies do not pay dividends. Nvidia's PEG ratio suggests it is undervalued, while Tesla's indicates expected significant growth. Analyst consensus suggests a 39.5% upside for Nvidia and a 5.32% downside for Tesla.

Portfolio Pulse from Neer Varshney

September 28, 2023 | 4:40 pm

BNOX

HC Wainwright & Co. analyst Joseph Pantginis has upgraded Bionomics (NASDAQ:BNOX) from Neutral to Buy and announced a price target of $8.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 4:33 pm

MRNA

A whale investor has taken a bullish stance on Moderna (NASDAQ:MRNA), with 50% of investors opening trades with bullish expectations and 50% with bearish. The whale has been targeting a price range from $65.0 to $120.0 for Moderna over the last 3 months. Argus Research has maintained their Buy rating on Moderna, with a price target of $140.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 4:32 pm

INSW

BTIG analyst Gregory Lewis maintains a Buy rating on International Seaways (NYSE:INSW) and raises the price target from $45 to $55.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 4:27 pm

MPC

A significant bullish stance has been taken on Marathon Petroleum (NYSE:MPC) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is split between 63% bullish and 36% bearish. The whales have been targeting a price range from $125.0 to $170.0 for Marathon Petroleum over the last 3 months. The price of MPC is up 1.73% at $155.06. Analysts from Mizuho, B of A Securities, Wells Fargo, and Raymond James have maintained their ratings on Marathon Petroleum.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 4:18 pm